Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: Prognosis and treatment of recurrences in a cohort study

European Journal of Surgical Oncology

Volumn 38, Issue 6, 2012, Pages 509-515

  Cashin, P H ^a   Graf, W ^a   Nygren, P ^b   Mahteme, H ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Colorectal cancer; Cytoreductive surgery; HIPEC; Intraperitoneal chemotherapy; Peritoneal carcinomatosis; Recurrences

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; HEMIHEPATECTOMY; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LIVER CANCER; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT SELECTION; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT CANCER; SEQUENTIAL POSTOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC THERAPY; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84860297306     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.03.001     Document Type: Article

References (28)

1. D. Elias, J.H. Lefevre, and J. Chevalier Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin J Clin Oncol 27 2009 681 685
2. J. Franko, Z. Ibrahim, N.J. Gusani, M.P. Holtzman, D.L. Bartlett, and H.J. Zeh Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis Cancer 116 2010 3756 3762
3. V.J. Verwaal, S. van Ruth, and E. de Bree Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 2003 3737 3743 (Pubitemid 46606227)
4. H. Mahteme, J. Hansson, and A. Berglund Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study Br J Cancer 90 2004 403 407 (Pubitemid 38250636)
5. D. Elias, J.-R. Delperro, and L. Sideris Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials Ann Surg Oncol 11 2004 518 521 (Pubitemid 40486734)
6. P.H. Sugarbaker, F.J. Gianola, J.C. Speyer, R. Wesley, I. Barofsky, and C.E. Meyers Prospective, randomized trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer Surgery 98 1985 414 422 (Pubitemid 16143766)
7. D. Elias, F. Gilly, and F. Boutitie Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a Multicentric French Study J Clin Oncol 28 2010 63 68
8. O. Glehen, F. Kwiatkowski, and P.H. Sugarbaker Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 2004 3284 3292 (Pubitemid 41103684)
9. F. Cavaliere, M. De Simone, and S. Virz Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O Eur J Surg Oncol 37 2011 148 154
10. V.J. Verwaal, S. van Ruth, A. Witkamp, H. Boot, G. van Slooten, and F.A.N. Zoetmulder Long-term survival of peritoneal carcinomatosis of colorectal origin Ann Surg Oncol 12 2005 65 71 (Pubitemid 40486643)
11. P. Shen, K. Thai, and J.H. Stewart Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients Ann Surg Oncol 15 2008 3422 3432
12. T.D. Yan, and D.L. Morris Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Ann Surg 248 2008 829 835
13. J. Esquivel, D. Elias, D. Baratti, S. Kusamura, and M. Deraco Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination J Surg Oncol 98 2008 263 267
14. J. Esquivel, R. Sticca, and P. Sugarbaker Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology Ann Surg Oncol 14 2007 128 133 (Pubitemid 44954279)
15. D.R. Carpizo, and M. D'Angelica Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease Lancet Oncol 10 2009 801 809
16. Klaver YL, Leenders BJ, Creemers GJ, et al. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin. Am J Clin Oncol doi:10.1097/COC.0b013e3182438c55 [Online February 6th, 2012].
17. Sommariva A, Pilati P, Rossi CR. Cyto-reductive surgery combined with hyperthermic intra-peritoneal chemotherapy for peritoneal surface malignancies: current treatment and results. Cancer Treat Rev doi:10.1016/j.ctrv.2011.07.001 [Online July 30, 2011].
18. V.J. Verwaal, H. Boot, B.M.P. Aleman, H. van Tinteren, and F.A.N. Zoetmulder Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome Ann Surg Oncol 11 2004 375 379 (Pubitemid 40486746)
19. A.G. Portilla, P.H. Sugarbaker, and D. Chang Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features World J Surg 23 1999 23 29 (Pubitemid 28565555)
20. L. Bijelic, T.D. Yan, and P.H. Sugarbaker Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms J Surg Oncol 98 2008 295 299
21. A. Brouquet, D. Goéré, and J.H. Lefvre The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome Ann Surg Oncol 16 2009 2744 2751
22. P.H. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
23. P. Jacquet, and P.H. Sugarbaker Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 1996 359 374
24. P. Sugarbaker Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. A manual for physicians and nurses 3rd ed. 1998 The Ludann Company Grand Rapids, MI
25. Cashin PH, Graf W, Nygren P, Mahteme H. Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study. Ann Oncol doi:10.1093/annonc/ mdr3012011 [Online June 17, 2011].
26. R.M. Smeenk, V.J. Verwaal, and F.A.N. Zoetmulder Learning curve of combined modality treatment in peritoneal surface disease Br J Surg 94 2007 1408 1414 (Pubitemid 350144391)
27. Dajani K, O'Reilly DA, Carino NDL, Ghaneh P, Poston G, Wu A. The prognostic significance of the preoperative full blood count after resection of colorectal liver metastases. HPB Surg doi:10.1155/2009/425065 [Online June 30, 2009].
28. M.C.G. van de Poll, Y.L.B. Klaver, V.E.P.P. Lemmens, B.J.M. Leenders, S.W. Nienhuijs, and I.H.J.T. de Hingh C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin Int J Colorectal Dis 26 2011 1067 1073